1. Home
  2. APPN vs HROW Comparison

APPN vs HROW Comparison

Compare APPN & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$23.19

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$33.83

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPN
HROW
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
APPN
HROW
Price
$23.19
$33.83
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
$33.83
$71.14
AVG Volume (30 Days)
633.3K
992.4K
Earning Date
05-07-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
0.02
N/A
Revenue
$226,743,000.00
N/A
Revenue This Year
$13.79
$32.90
Revenue Next Year
$10.56
$48.52
P/E Ratio
$1,199.50
N/A
Revenue Growth
28.29
N/A
52 Week Low
$21.77
$20.85
52 Week High
$46.06
$54.98

Technical Indicators

Market Signals
Indicator
APPN
HROW
Relative Strength Index (RSI) 34.36 34.70
Support Level $21.77 $32.55
Resistance Level $31.10 $41.49
Average True Range (ATR) 0.95 1.54
MACD -0.16 0.21
Stochastic Oscillator 4.89 19.45

Price Performance

Historical Comparison
APPN
HROW

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: